Unknown

Dataset Information

0

Long noncoding RNA FGF14-AS2 inhibits breast cancer metastasis by regulating the miR-370-3p/FGF14 axis.


ABSTRACT: Long noncoding RNAs (lncRNAs) have emerged as important regulators in cancers, including breast cancer. However, the overall biological roles and clinical significance of most lncRNAs are not fully understood. This study aimed to elucidate the potential role of a novel lncRNA FGF14-AS2 and the mechanisms underlying metastasis in breast cancer. The lncRNA FGF14-AS2 was significantly downregulated in breast cancer tissues; patients with lower FGF14-AS2 expression had advanced clinical stage. In vitro and in vivo assays of FGF14-AS2 alterations revealed a complex integrated phenotype affecting breast cancer cell migration, invasion, and tumor metastasis. Mechanistically, FGF14-AS2 functioned as a competing endogenous RNA of miR-370-3p, thereby leading to the activation of its coding counterpart, FGF14. Clinically, we observed increased miR-370-3p expression in breast cancer tissues, whereas FGF14 expression was decreased in breast cancer tissues compared to the adjacent normal breast tissues. FGF14-AS2 expression was significantly negatively correlated with miR-370-3p expression, and correlated positively to FGF14 expression. Collectively, our findings support a model in which the FGF14-AS2/miR-370-3p/FGF14 axis is a critical regulator in breast cancer metastasis, suggesting a new therapeutic direction in breast cancer.

SUBMITTER: Jin Y 

PROVIDER: S-EPMC7548970 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature

altmetric image

Publications

Long noncoding RNA FGF14-AS2 inhibits breast cancer metastasis by regulating the miR-370-3p/FGF14 axis.

Jin Yucui Y   Zhang Ming M   Duan Rui R   Yang Jiashu J   Yang Ying Y   Wang Jue J   Jiang Chaojun C   Yao Bing B   Li Lingyun L   Yuan Hongyan H   Zha Xiaoming X   Ma Changyan C  

Cell death discovery 20201012


Long noncoding RNAs (lncRNAs) have emerged as important regulators in cancers, including breast cancer. However, the overall biological roles and clinical significance of most lncRNAs are not fully understood. This study aimed to elucidate the potential role of a novel lncRNA FGF14-AS2 and the mechanisms underlying metastasis in breast cancer. The lncRNA FGF14-AS2 was significantly downregulated in breast cancer tissues; patients with lower FGF14-AS2 expression had advanced clinical stage. In vi  ...[more]

Similar Datasets

| S-EPMC7346038 | biostudies-literature
| S-EPMC7183609 | biostudies-literature
| S-EPMC7031989 | biostudies-literature
| S-EPMC7204052 | biostudies-literature
| S-EPMC6349183 | biostudies-literature
| S-EPMC8093613 | biostudies-literature
| S-EPMC7689242 | biostudies-literature
| S-EPMC8057948 | biostudies-literature
| S-EPMC5872400 | biostudies-literature
| S-EPMC7910476 | biostudies-literature